Advertisement
Screener

BioAmber Inc. Operating Cash Flow

BioAmber Inc. Operating Cash Flow

BioAmber Inc. reported Operating Cash Flow of -$4.87 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-05-13

  • BioAmber Inc. net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$4.87M.
  • BioAmber Inc. net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was -$5.95M.
  • BioAmber Inc. net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was -$5.34M.
  • BioAmber Inc. net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$2.17M.
  • BioAmber Inc. net cash provided by (used in) operating activities for fiscal 2013 was -$27.52M.
  • BioAmber Inc. net cash provided by (used in) operating activities for fiscal 2012 was -$32.28M.
  • BioAmber Inc. net cash provided by (used in) operating activities for fiscal 2011 was -$20.05M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 53 monthNet Cash Provided by (Used in) Operating Activities 56 monthNet Cash Provided by (Used in) Operating Activities 59 monthNet Cash Provided by (Used in) Operating Activities 62 monthNet Cash Provided by (Used in) Operating Activities 65 month
2014-03-31-$4.87M
10-Q · filed 2014-05-13
-$10.81M
derived: sum of 2 quarters · filed 2014-05-13
-$16.15M
derived: sum of 3 quarters · filed 2014-05-13
-$18.32M
derived: sum of 4 quarters · filed 2014-05-13
-$97.77M
10-Q · filed 2014-05-13
2013-12-31-$5.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$11.29M
derived: sum of 2 quarters · filed 2014-03-28
-$13.46M
derived: sum of 3 quarters · filed 2014-03-28
-$27.52M
10-K · filed 2014-03-28
-$92.90M
10-K · filed 2014-03-28
2013-09-30-$5.34M
10-Q · filed 2013-11-13
-$7.51M
derived: sum of 2 quarters · filed 2013-11-13
-$21.58M
10-Q · filed 2013-11-13
-$27.32M
derived: sum of 4 quarters · filed 2014-05-13
-$86.96M
10-Q · filed 2013-11-13
2013-06-30-$2.17M
10-Q · filed 2013-08-14
-$16.24M
10-Q · filed 2013-08-14
-$21.98M
derived: sum of 3 quarters · filed 2014-05-13
-$31.36M
derived: sum of 4 quarters · filed 2014-05-13
-$81.62M
10-Q · filed 2013-08-14
2013-03-31-$14.07M
10-Q · filed 2014-05-13
-$19.81M
derived: sum of 2 quarters · filed 2014-05-13
-$29.19M
derived: sum of 3 quarters · filed 2014-05-13
-$33.80M
derived: sum of 4 quarters · filed 2014-05-13
-$79.45M
10-Q/A · filed 2013-06-10
2012-12-31-$5.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$15.12M
derived: sum of 2 quarters · filed 2014-03-28
-$19.73M
derived: sum of 3 quarters · filed 2014-03-28
-$32.28M
10-K · filed 2014-03-28
2012-09-30-$9.38M
10-Q · filed 2013-11-13
-$13.99M
derived: sum of 2 quarters · filed 2013-11-13
-$26.53M
10-Q · filed 2013-11-13
2012-06-30-$4.61M
10-Q · filed 2013-08-14
-$17.00M
10-Q · filed 2013-08-14
2012-03-31-$12.39M
10-Q/A · filed 2013-06-10
2011-12-31-$20.05M
10-K · filed 2014-03-28